LARS Antikörper (AA 614-892) (HRP)
-
- Target Alle LARS Antikörper anzeigen
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Bindungsspezifität
- AA 614-892
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LARS Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Leucine--tRNA ligase, cytoplasmic protein (614-892AA)
- Isotyp
- IgG
- Top Product
- Discover our top product LARS Primärantikörper
-
anti-Leucyl-tRNA Synthetase (LARS) (AA 614-892) antibody
LARS Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 1118-1145), (C-Term) antibodyLARS Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB14824 unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 1-270) antibodyLARS Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 176-205), (N-Term) antibodyLARS Reaktivität: Maus WB, FACS Wirt: Kaninchen Polyclonal RB14919 unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 260-509) antibodyLARS Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (C-Term) antibodyLARS Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Leucyl-tRNA Synthetase (LARS) (AA 183-213), (N-Term) antibodyLARS Reaktivität: Human, Maus WB, FACS, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LARS (Leucyl-tRNA Synthetase (LARS))
- Andere Bezeichnung
- LARS (LARS Produkte)
- Hintergrund
-
Background: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs.
Aliases: cytoplasmic antibody, Cytoplasmic leucyl tRNA synthetase antibody, Cytosolic leucyl tRNA synthetase antibody, FLJ10595 antibody, FLJ21788 antibody, hr025Cl antibody, HSPC 192 antibody, HSPC192 antibody, KIAA1352 antibody, LARS 1 antibody, Lars antibody, LARS1 antibody, Leucine translase antibody, Leucine tRNA ligase antibody, Leucine--tRNA ligase antibody, Leucyl tRNA synthetase cytoplasmic antibody, Leucyl-tRNA synthetase antibody, LeuRS antibody, LEUS antibody, LRS antibody, PIG 44 antibody, PIG44 antibody, Proliferation inducing gene 44 antibody, RNTLS antibody, SYLC_HUMAN antibody
- UniProt
- Q9P2J5
- Pathways
- EGFR Signaling Pathway
-
